Major drugmaker loses $27 billion in market value after failed trial

Finance
by
2 hours ago 0 1

Two companies announced on Thursday that the heart disease drug they had been developing failed its Phase III trial.

Latest News
Finance
Schwab strategists warn of a major market shift: The era of easy index gains is officially over.
47 minutes ago
0 0
Finance
10 stocks for momentum traders to consider buying — and 10 to avoid or sell short
56 minutes ago
0 0
Finance
EXCLUSIVE: Union Pacific, Norfolk Southern CEOs talk about the rail merger that could reshape the U.S. economy  
56 minutes ago
0 0

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Comments

No comments to show.

© Copyright 2026 Glen Dross | Powered by WordPress | Mercury Theme
© Copyright 2026 Glen Dross
Powered by WordPress | Mercury Theme

Powered by
►
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
Powered by